Insider Transactions in Q1 2024 at Voyager Therapeutics, Inc. (VYGR)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 21
2024
|
Alfred Sandrock President and CEO |
SELL
Open market or private sale
|
Direct |
13,033
-3.75%
|
$91,231
$7.46 P/Share
|
|
Feb 21
2024
|
Robin Swartz Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,966
-3.24%
|
$27,762
$7.45 P/Share
|
|
Feb 21
2024
|
Todd Alfred Carter Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,365
-3.7%
|
$23,555
$7.47 P/Share
|
|
Feb 21
2024
|
Peter P. Pfreundschuh Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,764
-2.1%
|
$26,348
$7.46 P/Share
|
|
Feb 20
2024
|
Todd Alfred Carter Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
602
-0.66%
|
$4,214
$7.68 P/Share
|
|
Feb 09
2024
|
Sandell Jacquelyn Fahey Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,000
+25.2%
|
-
|
|
Feb 09
2024
|
Alfred Sandrock President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
130,000
+27.2%
|
-
|
|
Feb 09
2024
|
Robin Swartz Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+29.01%
|
-
|
|
Feb 09
2024
|
Todd Alfred Carter Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
38,500
+29.59%
|
-
|
|
Feb 09
2024
|
Peter P. Pfreundschuh Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+14.32%
|
-
|
|
Jan 17
2024
|
Todd Alfred Carter Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,266
-2.33%
|
$8,862
$7.18 P/Share
|
|
Jan 17
2024
|
Robin Swartz Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,543
-3.4%
|
$17,801
$7.15 P/Share
|